Clinical Trial Update: A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MELT-300 (midazolam and ketamine sublingual tablets) for sedation and intraoperative ocular analgesia in cataract extraction with lens …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• MELT-300

Snippet

Sponsor: Melt Pharmaceuticals | Conditions: Cataract | Phase 2 | Status: COMPLETED